Redeye has interviewed Neola Medical’s CEO, Hanna Sjöström, following the company’s Q3 2026 report. The report, the Breakthrough Device Designation and upcoming studies for the Neola device are discussed.
Click here to see the interview
About Redeye Nordic Growth AB
This is a press release from Redeye Nordic Growth AB, a equity research firm specializing in Nordic growth companies within Tech and Life Science. Redeye Nordic Growth is a part of the Redeye group, which also offers services within corporate finance advisory and fund management. https://services.redeye.se/
Attachments
Neola Medical (Q3 Interview): A major milestone and exciting year ahead